Suppr超能文献

切除术后胰腺导管腺癌患者的复发模式及其危险因素:272 例回顾性分析。

Recurrence pattern and its risk factors in patients with resected pancreatic ductal adenocarcinoma - A retrospective analysis of 272 patients.

机构信息

Department of General and Visceral Surgery, Friedrich-Alexander-University, Krankenhausstraße 12, Erlangen, Germany.

Department of General and Visceral Surgery, Friedrich-Alexander-University, Krankenhausstraße 12, Erlangen, Germany.

出版信息

Pancreatology. 2024 Sep;24(6):930-937. doi: 10.1016/j.pan.2024.07.017. Epub 2024 Aug 2.

Abstract

BACKGROUND

The aim of this study was to investigate the patterns of recurrence and their associated risk factors in patients who underwent resection for pancreatic carcinoma.

METHODS

This retrospective study included 272 patients, who underwent Ro/R1-resection of PDAC from 2005 to 2020 at the University Hospital Erlangen. Risk factors for different recurrence patterns and the prognostic value of recurrence pattern on the overall survival after recurrence were evaluated.

RESULTS

61 % of the patients experienced recurrence, mostly within the first 12 postoperative months (62 %) and in the form of metastases (87 %). The median overall survival from recurrence was 9.2 months. The preoperative absence of diabetes and the presence of lymph node metastasis were independent risk factors for recurrence and a preoperative CA19-9 exceeding 97 U/ml for early recurrence. Additionally, lymph node metastases were associated with a higher risk of metastatic recurrence. Early recurrence, but not the site of recurrence, was identified as an independent prognostic factor for worse overall survival from recurrence.

CONCLUSION

The occurrence of recurrence and especially of early and metastatic recurrence are associated with a worse overall survival. Patients lacking preoperative diabetes, having high preoperative CA19-9 values and lymph node metastases are particularly at risk for (early) recurrence.

摘要

背景

本研究旨在探讨接受胰腺癌切除术患者的复发模式及其相关的危险因素。

方法

本回顾性研究纳入了 2005 年至 2020 年期间在埃尔兰根大学医院接受 Ro/R1 切除术的 272 例 PDAC 患者。评估了不同复发模式的危险因素,以及复发模式对复发后总生存的预后价值。

结果

61%的患者出现复发,大多发生在术后 12 个月内(62%),且以转移的形式出现(87%)。复发后的中位总生存时间为 9.2 个月。术前无糖尿病和存在淋巴结转移是复发的独立危险因素,术前 CA19-9 超过 97 U/ml 与早期复发相关。此外,淋巴结转移与更高的转移性复发风险相关。早期复发而非复发部位被确定为复发后总生存的独立预后因素。

结论

复发的发生,尤其是早期和转移性复发与更差的总生存相关。术前无糖尿病、术前 CA19-9 水平较高和淋巴结转移的患者复发风险尤其高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验